Scientists have published a detailed plan for a future clinical trial. They want to see if combining two treatments helps improve thinking and memory problems in people with schizophrenia. The first treatment is called transcranial direct current stimulation (tDCS), a gentle form of brain stimulation. The second is cognitive remediation therapy, which is computer-based training for skills like memory and attention. The study will involve 120 adults with stable schizophrenia at a single clinic. Half will receive real brain stimulation before their cognitive training sessions, while the other half will receive a sham (fake) stimulation before the same training. The main goal is to measure changes in cognitive performance using a standard computer test battery. Researchers will also check for changes in schizophrenia symptoms and brain activity. The plan includes a follow-up assessment eight weeks after the treatment ends. Because this is only a study protocol, there are no results to report. We do not know if the combined treatment worked better than training alone, or if it caused any side effects. The main reason to be careful is that this document simply outlines what the researchers intend to do. It is not a report of findings. Readers should understand that this is a plan for research that has not yet been completed. The outcome of this trial could help inform future treatment approaches, but for now, there is no new evidence to consider.
Researchers plan trial to test brain stimulation plus cognitive training for schizophrenia
Photo by Navy Medicine / Unsplash
What this means for you:
This is a plan for a future study; no results on effectiveness or safety are available. More on Schizophrenia
Cariprazine showed modest weight reduction versus aripiprazole in schizophrenia patients previously treated with olanzapine. Cariprazine shows modest weight benefit over aripiprazole in schizophrenia patients
· May 1, 2026
GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates New drugs help people with severe mental illness lose weight safely
· May 1, 2026
Meta-analysis finds decreased GDNF levels in bipolar disorder but high heterogeneity limits conclusions Brain chemical levels differ in bipolar disorder compared to healthy people
· May 1, 2026
Meta-analysis reviews psychosis prevalence in bipolar disorder patients across 285 studies Psychosis common in bipolar disorder, review finds
· May 1, 2026